SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
911GILD in TROUBLE? It is obvious that to survive (as entity) GILD need to expand Miljenko Zuanic-11/1/2016
910Why not? Waste another 2 years for P2b? IF works...works! If not....did not loseMiljenko Zuanic-10/20/2016
909If we knew the answer, we would probably know why AGN paid a 500% premium to acqDewDiligence_on_SI-10/20/2016
908I know i am science limited, but why are they moving the NASH to p3? mopgcw-10/20/2016
907GILD dipping into bsAb, field of the next col-deal. finance.yahoo.comMiljenko Zuanic-7/8/2016
906Gilead escapes liability in hepatitis C patent fight with Merck finance.yahoo.cJulius Wong-6/6/2016
905Did Roche/GNE delayed SC Rituxan formulation? Better question is; Which Comp &qMiljenko Zuanic-5/31/2016
904GILD's TAF scam: siliconinvestor.comDewDiligence_on_SI15/29/2016
903The company that Gilead should consider buying right now So what should Gilead puborectalis-2/6/2016
902SA's Bret Jensen and followers are very positive on this stock: seekingalphPaul Senior-2/4/2016
901The new buyback program is for $12B (not $10B). Regards, DewDewDiligence_on_SI-2/3/2016
900Gilead Sciences ($GILD) announced a 10 percent increase to its dividend and an amore100-2/3/2016
899Gilead ($GILD) announced the termination of a Phase 2 clinical study of its invemore100-1/6/2016
898Gilead Sciences ($GILD) announced the FDA has granted priority review to its NDAmore100-1/5/2016
897Material news? All we get is ink blots?scaram(o)uche-12/18/2015
896$GILD Until the CEO goes and buy 2 to 3 companies with the cash it has, the stocSybilNicolas112/15/2015
895$GILD trade the volatility, try to think, weakness is a sale. Going on buy it anSybilNicolas-12/9/2015
894$GILD there will be many who will sell out of fear of what the political a will SybilNicolas-12/4/2015
893$GILD chart is a mess. Broke support so now expect 102 in play with cont'd dSybilNicolas-12/3/2015
892Determining an appropriate P/E ratio is not so easy for a company where sales maDewDiligence_on_SI-12/2/2015
891$GILD Keep in mind just for this company to maintain a measly 9.7 PE by this timSybilNicolas-12/2/2015
890$GILD nice block trades after hours today 53000 and 19000 at 105.96 appears to bSybilNicolas-12/1/2015
889$GILD could be ready. Thru 108.50 we see 110.50 and maybe 112. 106, 104 and 101 SybilNicolas-11/30/2015
888GILD gild presents three times this month and unblinds phase three TAF- hep b daSybilNicolas-11/27/2015
887$GILD 2 year weekly shows us exiting diamond with bounce off support much closerSybilNicolas-11/26/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News